NASDAQ: GEMP Investor Alert: Investigation of Certain Directors of Gemphire Therapeutics Inc.
An investigation on behalf of investors in Gemphire Therapeutics Inc. (NASDAQ: GEMP) shares over potential wrongdoing at Gemphire Therapeutics Inc. was announced and NASDAQ: GEMP stockholders should contact the Shareholders Foundation.
View full press release